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Abstract
Tricuspid valve endocarditis (TVE) continues to be on the rise and has been mostly 
attributed to the growing epidemic of intravenous drug abuse (IVDA). Other risk 
factors include long-term indwelling central venous catheters and implantable cardiac 
devices. While medical management continues to be the first line therapy, surgery is 
indicated when medical management fails, and in the presence of hemodynamic dete-
rioration, recurrent septic pulmonary embolization and/or persistent sepsis. Tricuspid 
valve (TV) excision once was the main surgical strategy, but other options include TV 
repair/reconstruction and replacement. Remaining challenges include management of 
drug-induced endocarditis and the best strategy for recurrent infection.
Keywords: endocarditis, tricuspid valve endocarditis, intravenous drug abuse, 
implantable cardiac devices
1. Introduction
Infective endocarditis remains a serious disease that is associated with significant 
morbidity and mortality. The overall incidence is relatively low, about 5/100,000 
person-years [1]. In the current era, aggressive medical therapy and earlier surgical 
interventions with few exceptional circumstances have been the goal. Recent litera-
ture shows relatively stable mortality rates, despite the improvement in diagnostic 
and therapeutic tools including medical therapy and surgical techniques [2]. Isolated 
TVE overall is less common in comparison to left sided endocarditis. In a study of 801 
adult patients with endocarditis, tricuspid or multivalvular involvement was present 
in 31.2% and this was a significant risk factor of early mortality on multivariate analy-
sis [3]. The incidence of TVE is increasing, mostly related to the growing epidemic of 
drug abuse. In the report by Seratnahaei et al., the incidence of tricuspid endocarditis 
increased from 6% between 1999 and 2000 to 36% between 2009 and 2010 [4].
2. Epidemiology
Right-sided endocarditis occurs at lower incidence in comparison to left-sided 
infection due to the less common pathology that involves the right heart in addition 
to the lower pressures and decrease oxygen content in comparison to the left side of 
the heart [5].
Right-sided endocarditis represents 5–10% of infective endocarditis cases [6], 
and TVE constitutes the majority of these cases. Of all surgeries for endocarditis in 
North America, 4.1% involves TVE [7].
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3. Natural history
Isolated TVE has been reported to have a favorable prognosis and good response 
to medical therapy with few exceptions. Ginzton and colleagues studied 16 patients 
(12 had history of IVDA) with TVE to define echocardiographic criteria to help 
identifying those at risk for complications or need for TV surgery [8]. The authors 
concluded that TV vegetations tend to resolve with time, however, those with per-
sistent infection, cardiomegaly and right heart failure are at increased risk, and no 
M mode or two-dimensional echocardiographic feature is a predictor of outcome.
This tendency for TV vegetations to resolve overtime is different from left-sided 
endocarditis which tend to persist. This could be related to bacteriological cure or 
silent embolization to the lung overtime.
4. Risk factors
• Intravenous Drug Abuse (IVDA)
 ○ This is the most common predisposing factor for right sided endocarditis 
and it ranges between 2 and 5% per year.
 ○ Approximately 15 opioid overdose deaths and 5 heroin overdose death per 
100,000 population reported in 2016, in comparison to 6 opioid overdose 
deaths and one heroin overdose death per 100,000 population in 2010, 
according to the Centers for Disease Control data [9]. This growing epidemic 
of drug abuse constitutes a major risk factor for TVE. In an analysis of the 
Society of Thoracic Surgeons national database, isolated TV operations were 
performed in 1613 patients with intravenous drug-associated TV endocardi-
tis between 2011 to 2016 [10].
 ○ Structural abnormalities of the TV have been noticed in those with chronic 
use of injected drugs. These abnormalities have been visualized by echocar-
diography and include leaflet thickening, and/or prolapse with or without 
regurgitation [11].
• Long-term Indwelling Catheters
 ○ One of the most common complications of long-term indwelling central 
venous catheters that are used for long-term hemodialysis or long-term 
delivery of medications such as chemotherapy has been infection [12]. The 
incidence of this type of infection is increasing and is parallel to the increase 
use of indwelling central venous catheters. In the United Sates, it is estimated 
that about 35,000 cases of catheter-related Staphylococcus aureus infection 
are reported each year with 6% of them developing into endocarditis [13].
• Implantable Cardiac Devices
 ○ This is a severe type of infection that is seen in patients with permanent 
pacemakers and defibrillators, and its incidence has been on the rise due to 
the increase use of these devices. In a prospective study of 2760 patients by 
Athan et al. [14], the incidence of cardiac device-related infection was 6.4%. 
Coexisting valvular involvement was present in 37.3%, of which 24.3% was 
TVE.
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 ○ The risk of infection after pacemaker implantation is 0.5–1% in the first year 
after implantation and with the increase complexity of the implanted device, 
and the need for device replacement or revision procedures, it increases 
further [15].
• Congenital Heart Defects
 ○ Patients with ventricular septal defect (VSD) and left-to-right shunts are 
at risk of endocarditis. TV involvement occurs secondary to the jet lesion 
against the anterior or the septal leaflets of the TV. Current guidelines do not 
recommend endocarditis prophylaxis anymore in those with acyanotic heart 
defects due to the low risk of its occurrence in this population [16].
 ○ Endocarditis in the presence of atrial septal defects is extremely rare due to 
the slow velocity of the shunt flow, and only few reported cases exist in the 
literature. An explanation of such occurrence could be related to the devel-
opment of tricuspid regurgitation secondary to right ventricular volume 
overload which increases the risk of TV involvement [17].
5. Microbiology
The most predominant organism is Staphylococcus aureus (60–90%). In IVDA, 
there has been an increase in methicillin-resistance and polymicrobial infection 
[18]. Coagulase-negative Staphylococcus infection occurs more frequently in the 
presence of prosthetic valves and indwelling central catheters. Although infection 
with Streptococci can occur (<10%), it remains higher in left-sided endocarditis 
[19]. There is also increase in infection with Pseudomonas and other gram-negative 
bacteria. Fungal infection is not uncommon and has been associated with high 
mortality especially in immunocompromised patients and those with intracardiac 
devices [20].
6. Clinical presentations
Clinical presentation may vary depending on degree of involvement/destruction 
of the tricuspid valve and presence or absence of complications. The most common 
presentation has been persistent fever, chills, anorexia, fatigue, cough, dyspnea, 
dizziness, cardiac murmur, and varying degrees of heart failure. Septic shock may 
occur in severe cases.
7. Complications of tricuspid endocarditis
The most common complications are related to valvular destruction with subse-
quent varying degrees of tricuspid regurgitation. Large vegetations can lead to val-
vular obstruction or recurrent septic pulmonary embolization (Figure 1(A)) and 
hemoptysis or pulmonary abscesses (Figure 1(B)). This repeat pulmonary emboli-
zation can result in elevation of the right-sided pressures, which in the presence of 
atrial level shunting, can lead to systemic embolization as well [21]. In severe cases, 
abscess formation is not uncommon [22], so as varying degrees of atrioventricular 
block. Acute diffuse glomerulonephritis secondary to immune complex formation 
and complement C3 deposition in the renal glomeruli resulting in acute renal failure 
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has been reported with Staphylococcus aureus [23]. When sepsis is uncontrolled, this 
can lead to right heart failure, septic shock, and multiorgan failure.
Acquired VSD can occur after an episode of endocarditis. Gerbode described in 
1958 [24] an acquired form of left ventricular-to-right atrial shunting with success-
ful repair. Acquired Gerbode defect is a type of paramembranous VSD that is asso-
ciated with left ventricular-to-right atrial shunting which can occur above (Type I), 
below (Type II) or both sides (Type III) of the septal leaflet of the TV [25].
8. Diagnosis
Diagnosis depends on high index of suspicion and by identifying the patient’s 
risk factors and the occurrence of the usual manifestation of infection such as 
persistent fever and other signs of bacteremia. Echocardiography remains the 
most appropriate initial test in these patients. Both transthoracic and transesopha-
geal modalities are important to confirm the diagnosis, identify the presence of 
vegetations (Figure 2; Video 1—https://bit.ly/3mDCQxK), evaluate the degree 
of TV destruction/regurgitation (Video 2—https://bit.ly/3mDCQxK), rule out 
any intra-cardiac shunts and evaluate the left side of the heart for any evidence of 
multivalvular involvement.
Figure 1. 
(A and B). Preoperative computed tomography scan in a patient with isolated tricuspid valve endocarditis 
secondary to intravenous drug use showing: (A) multiple bilateral septic pulmonary emboli with cavitation. 
Notice in (B), the development of necrotic changes with possible abscess (asterisk) formation in the left lung.
Figure 2. 
A large tricuspid valve vegetation (1.9 × 1.2 mm) is shown on preoperative transthoracic echocardiography. RA: 
Right atrium; RV: Right ventricle.
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Computed tomography (CT) scan is indicated to evaluate the lung parenchyma 
and vasculature. Due to the difficulty in diagnosing septic pulmonary emboli, we 
obtain chest CT scan routinely as this may change the timing of intervention. Other 
relevant tests depend on presence of other systemic manifestations of infection/
embolization may include other cross-sectional imaging, brain imaging etc.
It is important to know that it is difficult to apply the Duke’s criteria [26] to diag-
nose TVE due to: (1) the unique anatomy of the structures in the right side of the heart 
which could simulate vegetations, (2) embolization if occurred is pulmonary rather 
than systemic which is difficult to diagnose until it evolves into pulmonary infarcts or 
abscesses, and (3) many of the radiologic findings can be mistaken for pneumonia.
9. Treatment
• Medical Treatment
In general, right-sided endocarditis resolves with medical treatment in the 
majority of cases (70–85%).
• Surgical Treatment
Although antibiotics remained the first line treatment for TVE, several patients 
may fail this line of therapy and require surgical interventions. In addition, 
those who have residual TV regurgitation will need either early or late recon-
struction or replacement of the TV.
 ○ Indications for Surgical Intervention
The following constitutes reasonable indications for surgical intervention [27]:
1. Right heart failure secondary to severe tricuspid regurgitation with poor  
response to medical therapy.
2. Persistent bacteremia/sepsis (> 7 days) with poor response to antibiotics which 
sometimes occurs in the presence of a highly virulent bacteria (Staphylococcus 
aureus, and Pseudomonas bacteremia), and infection with organisms that are 
difficult to eradicate such as fungi.
3. Recurrent septic pulmonary embolism with or without right heart failure.
4. Large TV vegetations (>20 mm) with or without right heart failure.
5. Abscess (more common in the presence of a prosthesis)
 ○ Timing of Surgery
While the exact timing of surgery remains unclear in many of these scenarios, 
it should be a team approach in decision with input from the cardiologist, cardiac 
surgeon, and the infectious disease specialist. In absence of urgent/emergent  
surgical indications (persistent sepsis, recurrent septic embolization, and heart 
failure), surgery is usually done on elective basis after a good duration of antibiotic 
therapy and appearance of negative blood cultures. This increases the chance of 
successful valve repair and minimize risk of recurrent infection. Decision is a bit 
more complicated in IVDA and in those with recurrent endocarditis.
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Other factors that may affect the timing include: (1) the presence of infected 
intracardiac devices, (2) the causative organism (fungal may not respond to medical 
therapy), and (3) the presence of concomitant left-sided infection.
 ○ Surgical Options
The principles of surgical treatment for isolated TVE follows the same principles 
in endocarditis cases which include thorough debridement, vegetation removal 
(Figure 3), and excision of all infected non-viable tissues. The preference after 
that will be to minimize the use of prosthetic materials especially in patients with 
history of IVDA and to attempt TV repair if possible.
 ○ Tricuspid Valvectomy
Excision of the TV has been proposed for those with massive valvular destruc-
tion and concerns with compliance to therapy, continued IVDA, and increased risk 
with repeat operations for infected prosthetic TV [28]. In the presence of low-nor-
mal pulmonary vascular resistance, this option may work as a temporary measure 
till sepsis is controlled.
The downside of this approach is right heart failure with development of ascites, 
peripheral edema and low cardiac output and this should be considered as a bridge 
for valve replacement once infection is cleared.
 ○ Tricuspid Valve Repair
TV repair should be strongly considered especially in IVDA cases to minimize the 
use of prosthetic materials and prosthesis that can lead to recurrent infection. The 
technique of valve reconstruction depends on the degree of valvular destruction:
1. Direct Suturing: suitable for small defects that is limited to one or two leaflets.
Figure 3. 
Intraoperative photo showing a large, excised vegetation from the posterior leaflet of the tricuspid valve. 
This was performed in a 16-year-old who presented with isolated tricuspid valve endocarditis secondary to 
intravenous drug abuse and underwent successful tricuspid valve repair after excision of the vegetations.
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2. Patch Repair (Figure 4): our preference has been to use autologous pericar-
dium or bovine pericardium to repair larger defects in the leaflet after excision 
of the vegetation and debridement of infected tissues.
3. Leaflet Replacement: a complete replacement of one leaflet can be performed 
using a variety of materials such as autologous or bovine pericardium. Multiple 
artificial chordae (neo-chordae) may be needed to join the newly formed leaf-
let with the papillary muscles of the TV and prevent prolapse.
4. Bicuspidization of the TV: this is suitable more when infection is localized 
to the posterior leaflet which can be excised, and both the anterior and septal 
leaflets are mobilized to form a bicuspid valve.
5. Annuloplasty: annuloplasty maneuvers are needed when the tricuspid annu-
lus is dilated to support the repair and minimize recurrence of regurgitation. 
This varies from suture annuloplasty (Kay’s or De Vega’s) to a ring annulo-
plasty (Figure 5(A) and (B)). Several studies reported that ring annuloplasty 
is superior to suture annuloplasty in terms of recurrence of regurgitation [29].
Figure 5. 
(A and B). Intraoperative photos showing the technique of tricuspid valve ring annuloplasty. We prefer to 
use non-pledgeted prolene sutures in a horizontal mattress fashion (A) to secure the ring due to the fragility 
of the right atrioventricular junction. It is important to secure the ring from the anteroseptal to posteroseptal 
commissures. The last stitch (pledgeted) is placed within the mouth of the coronary sinus which is critical to 
reduce the length of the inferior annulus as most of the recurrence of regurgitation occurs due to re-dilation of 
the tricuspid annulus in this area.
Figure 4. 
Intraoperative photo showing a bovine pericardial patch that is used to augment the septal leaflet of the 
tricuspid valve and improve coaptation in a patient who presented with severe tricuspid valve regurgitation 
and history of endocarditis. Notice that augmentation should be done in the belly of the leaflet and not at the 
free leading edge. Also notice the area of the atrioventricular node (asterisk).
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 ○ Tricuspid Valve Replacement
While TV repair is preferred, TV replacement remains the most commonly 
performed procedure [30]. Bioprostheses have been the first choice but  
mechanical prostheses have been also used in these cases. In a study by Cho et al., 
there was no difference in long-term valve-related complications such as  
thromboembolic or bleeding events between mechanical and biological  
prostheses [31].
Total autologous reconstruction of the TV using autologous/bovine pericardium 
or extracellular matrix reconstruct has been reported in some case reports to avoid 
the use of the prosthetic materials in the setting of infection [32]. We do not know 
the long-term outcome of such maneuvers.
• Special Circumstances
 ○ Isolated TV Vegetations without Valvular Destruction
In some unique scenarios, large vegetations have been identified on the tricus-
pid valve without any evidence of valvular destruction or in some patients where 
the risk of surgery is quite high. Percutaneous aspiration of these large vegeta-
tions has been performed as an alternative to surgery [33]. The AngioVac system 
(AngioDynamics, Latham, NY) was approved in 2014 by the US Food and Drug 
Administration for removal of intravascular materials such as thrombi and emboli.
This system consists of two percutaneous venous cannulae (reinfusing/drain-
age) that are connected to an extracorporeal circuit pump head and bubble trap. 
Thrombotic materials/vegetations are aspirated when the pump is started and then 
the blood is circulated through a filter prior to returning to the patient. In a study by 
George et al., the authors reported the outcomes of percutaneous aspiration in 33 
patients with large vegetations. Most of these patients (91%) were discharged home 
with reduced vegetations size in two-thirds [34]. This seems to be a reasonable 
option especially in those with prohibitive risk of surgery and in those with recur-
rent infection especially IVDA.
The obvious risks associated with percutaneous aspiration includes pulmonary 
embolization and vascular access complications.
 ○ Prosthetic Tricuspid Valve Endocarditis
In the presence of TV prosthesis, infection will be difficult to eradicate without 
removal of the prosthesis. This subgroup of patients may require early and aggres-
sive surgical eradication of infection to minimize in-hospital mortality and mor-
bidities. There is a higher risk of heart block in this subgroup of patients.
 ○ Management of Implantable Cardiac Devices/Indwelling Catheters
All infected leads and devices have to be removed. Hospital mortality is less 
when infected devices are identified earlier and removed promptly. Extraction 
of these devices by interventional cardiologist/electrophysiologist is preferred if 
possible, over the surgical extraction due to higher success and lower complication 
rates. One option, in less severe cases, is to remove these infected leads/devices, use 
temporary leads for pacemaker-dependent patients and continue antibiotic therapy 
and reevaluate the TV later, if repair or replacement is needed.
In severe cases that require urgent surgery, TV repair/replacement with con-
comitant extraction of the infected leads/devices is a better approach. Temporary 
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pacemaker leads can be used with subsequent endovenous implantation of a new 
permanent system once infection is cleared is a reasonable approach.
Other options for pacemaker-dependent patients is to use leadless pacemakers or 
trans-coronary sinus approach to avoid placing the lead through a freshly repaired 
TV or replaced tricuspid prosthesis. We have used epicardial permanent pacemaker 
system as well in some of these complex cases with limited vascular access.
This is a team decision that should be discussed thoroughly between the electro-
physiologist, cardiologists, cardiac surgeon, and the patient.
 ○ Concomitant Left Sided Disease (Multi-valvular Endocarditis)
Those with left sided involvement have worse outcomes in comparison with 
isolated TVE. These patients will require early surgical intervention to decrease 
mortality and improve outcomes. In a study by Musci and colleagues, 30-day 
survival was 96.2% for isolated right sided involvement in comparison to 72% for 
combined right and left-sided endocarditis [35].
 ○ Mycotic Aneurysms
Mycotic aneurysms involving the pulmonary vasculature are less common and 
small number of cases have been reported in the literature [36]. Staphylococcus and 
streptococcus species are the most common organisms involved in developing these 
aneurysms, but it can also occur in the settings of mycobacterial or fungal infec-
tions. Clinical manifestations are usually related to the underlying endocarditis and 
manifestations specific to these mycotic aneurysms are rare except when rupture 
occurs which can lead to catastrophic hemoptysis.
Computed tomography scan is the most reliable for detection of these aneu-
rysms. Due to the high mortality associated with rupture of these aneurysms, 
transcatheter embolization is recommended, although successful antibiotic therapy 
have been documented in those with small aneurysms that are stable [37].
 ○ Concomitant Pulmonary Emboli
In patients with TV endocarditis and large vegetations, the search for evi-
dence of pulmonary embolization is necessary especially in the presence of 
hemodynamic instability or acute new pulmonary manifestations. Concomitant 
pulmonary embolectomy at the time of TV surgery may be considered in 
patients with large bilateral/unilateral emboli especially if they are accessible. 
We have performed a retrograde pulmonary embolectomy in a recent case of 
TVE in an IVDA with CT evidence of bilateral pulmonary septic emboli. This 
technique is valuable in the presence of emboli in the distal pulmonary arterial 
bed that may not be accessible with the traditional pulmonary embolectomy 
technique [38].
 ○ Recurrent Endocarditis
The highest risk of recurrence occurs among those with IVDA [39]. In a study 
by Huang and colleagues, the authors followed 87 patients who survived their first 
episode of endocarditis and up to 25% of these patients experienced recurrence 
of infection within a year of the first episode [40]. Outcomes of repeat operation 
in this population has been poor with increased mortality. In another study by 
Jeganathan and colleagues, 68 patients underwent repeat TV operations with early 
mortality of 13.2% and higher incidence of postoperative bleeding, low cardiac 
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output syndrome, renal failure, and stroke [41]. A debate continues regarding 
offering IVDA patients and those who are noncompliant, repeat surgery when 
infection recurs.
10. Prognosis
The majority of TVE respond to medical therapy but is associated with higher 
risk of recurrence, specifically in IVDA.
The overall prognosis of isolated TV endocarditis is better than left-sided and 
multivalvular infection. This may be due to younger age of patients, less occur-
rence of systemic embolization or development of drug-resistance, in addition to 
the fewer significant hemodynamic derangements that may occur from tricuspid 
regurgitation in contrast to aortic and/or mitral involvement.
The following have been associated with poor prognosis according to several 
reports: (1) persistent sepsis with failure to respond to medical therapy, (2) 
development of right heart failure, (3) fungal infection, (4) recurrent pulmonary 
embolization, (5) septic shock, and (6) multivalvular involvement.
11. Surgical outcomes
The estimated operative mortality for surgery for TVE is between 6 and 10% 
[42]. Excision of the TV has been associated with high morbidity due to right heart 
failure [43], and TV replacement has been associated with increased risk of recur-
rent infection and need for permanent pacemaker.
Yanagawa and colleagues reported the outcome sin 1165 patients who underwent 
surgery for TVE. The indications were recurrent pulmonary embolization, right 
heart failure, persistent sepsis and concomitant left-sided infection. TV repair was 
possible in 2/3 of these patients and the majority underwent TV replacement with 
a bioprosthesis. The authors concluded that both TV repair and replacement have 
good long-term survival, but repair is associated with less risk of need for pace-
maker, recurrence of infection and reoperation [44].
Di Mauro et al. reported the surgical outcomes of isolated TVE in 157 patients 
(IVDA was present in 38%) of a multicenter registry. Repair was performed in 
49%, while replacement with a bioprosthesis was the main procedure in 46% and a 
mechanical prosthesis was used in 5%. Early mortality was 11% with no difference 
between repair or replacement. The authors identified the following factors as pre-
dictors of poor outcomes: older age, IVDA, fungal endocarditis, repeat operation, 
the use of a prosthesis, and the presence of intracardiac devices [45].
In a recent systemic review and metanalysis of 752 patients with TVE by Luc and 
colleagues, tricuspid valvectomy was performed in 14%, while 86% underwent TV 
replacement. There was more prolonged duration of mechanical ventilation in the val-
vectomy group, but there was no significant difference in early mortality, right heart 
failure and recurrence of endocarditis between the two groups. The authors concluded 
that tricuspid valvectomy is an acceptable initial therapy in those with IVDA to help 
identify those who will self-select as candidates for later valve replacement [46].
12. Conclusions
TVE has several features that are unique in comparison to left-sided infec-
tion. These include the different population demographics, etiology of infection, 
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response to medical therapy and prognosis. High index of suspicion and use of 
appropriate imaging modalities facilitate early diagnosis and early initiation of 
appropriate therapy. Surgery remains indicated in those with failure to respond 
to medical therapy and in the presence of complications. The same principle of 
surgery for endocarditis apply which are adequate and thorough debridement of 
all infected materials and excision of all vegetations. Extraction of all associated 
infected cardiac devices is critical to ensure complete eradication of all sources of 
infection. Excision of the TV is associated with higher morbidity due to ongoing 
right heart failure, and TV repair is preferred over replacement if feasible. Debate 
remains ongoing in regard to offering surgery for those with recurrent infection and 
specifically IVDA.
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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